Latest Ramoplanin Stories

2009-08-03 19:07:22

With the "last resort" antibiotic Vancomycin now plagued by the first signs of bacterial resistance, a scientific collaboration centered at Duke University has identified how a candidate successor antibiotic known as Ramoplanin A2 can kill pathogenic bacteria by interrupting how they form their cell membranes.During a 12-year quest, the research team had to learn how to crystallize Ramoplanin's molecular structure at the crucial time and place that it interacts with the bacterium's membrane....

2007-09-07 12:00:11

The United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance to Oscient Pharmaceuticals (Nasdaq: OSCI) for a U.S. patent relating to methods of use of Ramoplanin for the treatment of Clostridium difficile-associated disease (CDAD), a serious form of colitis. Ramoplanin is a glycolipodepsipeptide antibiotic positioned for Phase III development for the potential treatment of CDAD, pending the conclusion of ongoing partnership discussions. A Notice of Allowance is...

Word of the Day
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.